Determining Intestinal Permeability Using Lucifer Yellow in an Apical-Out Enteroid Model
July 27th, 2022
3.5K views
The present protocol outlines a method that utilizes lucifer yellow in an apical-out enteroid model to determine intestinal permeability. This method can be used to determine paracellular permeability in enteroids that model inflammatory bowel diseases such as necrotizing enterocolitis.
Overview
This protocol describes a method using lucifer yellow in an apical-out enteroid model to assess intestinal permeability. It is particularly relevant for studying inflammatory bowel diseases like necrotizing enterocolitis.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Gastroenterology
Background
- Lucifer yellow is a fluorescent dye used to evaluate permeability.
- Enteroids are 3D models that mimic intestinal tissue.
- Paracellular permeability is crucial for understanding intestinal health.
- This method can be applied to various intestinal diseases.
Purpose of Study
- To develop a reliable method for assessing intestinal permeability.
- To utilize enteroid models for studying human intestinal diseases.
- To investigate the mechanisms underlying necrotizing enterocolitis.
Methods Used
- Application of lucifer yellow to the media of apical-out enteroids.
- Growing enteroids embedded in BMM for 7-10 days.
- Using 50% LWRN conditioned media for enteroid generation.
- Conducting quantitative and qualitative analysis of permeability pathways.
Main Results
- Demonstrated a straightforward technique for permeability assessment.
- Showed potential applications in various intestinal diseases.
- Highlighted the role of enteroids in studying disease mechanisms.
- Involved collaboration among research scholars and assistants.
Conclusions
- The lucifer yellow method is effective for studying intestinal permeability.
- Apical-out enteroids provide a valuable model for research.
- This technique can enhance understanding of intestinal diseases.
Frequently Asked Questions
What is lucifer yellow used for?
Lucifer yellow is used to assess intestinal permeability in research.
How are enteroids generated?
Enteroids are grown in BMM with conditioned media for 7-10 days.
What diseases can this method help study?
It can be used to study various intestinal diseases, including necrotizing enterocolitis.
Who conducted the study?
The study was conducted by Dr. Tyler Leiva, Dr. Alena Golubkova, and Camille Schlegel.
What are the benefits of using 3D models?
3D models like enteroids better mimic human intestinal tissue compared to 2D models.
Is this method applicable to other research areas?
Yes, it can be adapted for various studies related to intestinal health.
Executive Industry Relevance
Quantitative assessment of intestinal permeability using lucifer yellow in apical-out enteroid models enables robust interrogation of epithelial barrier function in disease-relevant human systems. This approach supports predictive confidence in early-stage target validation and mechanistic de-risking for gastrointestinal drug discovery portfolios. The model's ability to capture all major paracellular pathways enhances translational continuity from discovery to preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct measurement of epithelial barrier integrity in human-derived 3D systems.
- Supports mechanistic de-risking by quantifying paracellular permeability changes under disease-mimicking conditions.
- Facilitates functional target validation for pathways implicated in barrier dysfunction.
- Provides predictive confidence for advancing GI disease targets.
Screening & Assay Development
- Delivers standardized, reproducible quantitative readouts of permeability using lucifer yellow fluorescence.
- Prepares validated enteroid systems for downstream compound screening and functional assays.
- Enables scalability and platform reuse across multiple intestinal disease models.
- Supports reliable evaluation of candidate interventions affecting barrier function.
Translational & Preclinical Research
- Aligns with disease-relevant human tissue models for translational biomarker development.
- Maintains continuity from discovery-stage mechanistic studies to preclinical validation of barrier-modulating therapies.
- Reduces translational risk by modeling host-pathogen interactions in a physiologically relevant context.
- Supports risk-adjusted advancement decisions for GI therapeutic programs.
Pipeline & Workflow Integration
This lucifer yellow-based permeability assay positions within the discovery-to-preclinical continuum, bridging early mechanistic studies and translational research in gastrointestinal disease models.
- Discovery Biology: Quantifies barrier function changes to clarify disease mechanisms and validate therapeutic hypotheses.
- Screening: Provides reproducible, quantitative permeability outputs for assay readiness and compound triage.
- Analytics: Generates fluorescence-based measurements enabling statistical comparison of experimental conditions.
- Translational Research: Connects in vitro findings to preclinical biomarker strategies in human-relevant systems.
- Enterprise Reuse: Establishes a reusable enteroid platform adaptable to diverse GI disease research needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in barrier function studies.
- Operational Value: Standardizes permeability assessment with scalable, reproducible workflows.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by de-risking early-stage GI programs.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of barrier-targeted therapeutic candidates.
Implementation Considerations
- Requires expertise in 3D enteroid culture and fluorescence-based analytics.
- Needs access to fluorescence plate readers and immunofluorescence microscopy infrastructure.
- Demands rigorous cross-team standardization of washing and quantification steps for reproducibility.
- Adaptable to various human intestinal disease models with appropriate tissue sourcing and validation.
- Dependent on thorough removal of extraluminal dye to ensure accurate permeability quantification.
Biopharma FAQs
Why does null hypothesis testing matter for lucifer yellow permeability assays?
Null hypothesis testing in lucifer yellow permeability assays enables objective determination of whether experimental treatments, such as LPS and hypoxia, significantly alter epithelial barrier function compared to controls. This statistical rigor is essential for target validation and mechanistic de-risking in GI drug discovery. Reliable hypothesis testing supports confident advancement decisions in the discovery pipeline.
How does independent variable isolation fit the enteroid permeability workflow?
Isolating variables like LPS exposure and hypoxic conditions in the enteroid model allows precise attribution of observed permeability changes to specific experimental factors. This clarity strengthens mechanistic insights and supports robust target validation for barrier-modulating interventions. Controlled variable isolation is critical for reproducible and interpretable R&D outputs.
What do quantitative lucifer yellow measurements enable in GI research?
Quantitative lucifer yellow fluorescence measurements provide standardized, reproducible readouts of paracellular permeability across experimental conditions. These outputs enable direct comparison of barrier function, facilitate compound screening, and support statistical analysis for decision-making. Quantitative data underpin predictive confidence in early-stage GI research.
Why are replication requirements important for cross-functional permeability studies?
Replication of lucifer yellow permeability assays ensures that observed effects are robust and reproducible across different operators and experimental runs. This reliability is essential for cross-functional collaboration, assay transferability, and enterprise-wide adoption of the enteroid platform. Consistent replication supports portfolio-level confidence in barrier function data.
What statistical analysis capabilities are required before implementing lucifer yellow assays?
Implementation of lucifer yellow permeability assays requires statistical software capable of generating standard curves, interpolating fluorescence data, and performing significance testing. These analytical capabilities ensure accurate quantification and rigorous evaluation of experimental outcomes. Robust statistical analysis is foundational for actionable R&D insights.
Chapters in this video
0:04
Introduction
0:59
Generation of Apical‐Out (AO) Enteroids
3:08
Induction of Experimental Necrotizing Enterocolitis (NEC)
5:06
Measurement of Paracellular Permeability Utilizing Lucifer Yellow (LY)
7:49
Results: Determining the Intestinal Permeability Using Lucifer Yellow in an Apical‐Out Enteroid Model
9:07
Conclusion
